Logo image of AMCI

AMCI ACQUISITION CORP II-A (AMCI) Stock Fundamental Analysis

NASDAQ:AMCI - Nasdaq - US00166R1005 - Common Stock - Currency: USD

9.91  -0.06 (-0.6%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to AMCI. AMCI was compared to 0 industry peers in the Unkown industry. AMCI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AMCI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AMCI was profitable.
In the past year AMCI has reported a negative cash flow from operations.
AMCI Yearly Net Income VS EBIT VS OCF VS FCFAMCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 -500K -1M

1.2 Ratios

Industry RankSector Rank
ROA 0.42%
ROE 0.44%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMCI Yearly ROA, ROE, ROICAMCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 -0.2 -0.4 -0.6

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMCI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMCI Yearly Profit, Operating, Gross MarginsAMCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

There is no outstanding debt for AMCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMCI Yearly Shares OutstandingAMCI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2021 5M 10M 15M 20M 25M
AMCI Yearly Total Debt VS Total AssetsAMCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2021 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 18.21 indicates that AMCI is not in any danger for bankruptcy at the moment.
AMCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.21
ROIC/WACCN/A
WACCN/A
AMCI Yearly LT Debt VS Equity VS FCFAMCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2021 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.07 indicates that AMCI may have some problems paying its short term obligations.
A Quick Ratio of 0.07 indicates that AMCI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
AMCI Yearly Current Assets VS Current LiabilitesAMCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2021 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

AMCI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -39.33% yearly.
EPS 1Y (TTM)N/A
EPS 3Y-39.33%
EPS 5YN/A
EPS Q2Q%165.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AMCI is valuated quite expensively with a Price/Earnings ratio of 330.33.
When comparing the Price/Earnings ratio of AMCI to the average of the S&P500 Index (24.85), we can say AMCI is valued expensively.
Industry RankSector Rank
PE 330.33
Fwd PE N/A
AMCI Price Earnings VS Forward Price EarningsAMCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMCI Per share dataAMCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMCI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMCI ACQUISITION CORP II-A

NASDAQ:AMCI (2/8/2023, 8:10:23 PM)

9.91

-0.06 (-0.6%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14 2022-11-14
Earnings (Next)03-27 2023-03-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap185.81M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 330.33
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB 1.28
EV/EBITDA N/A
EPS(TTM)0.03
EY0.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS7.74
TBVpS7.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 0.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 18.21
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3Y-39.33%
EPS 5YN/A
EPS Q2Q%165.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y72.06%
OCF growth 3YN/A
OCF growth 5YN/A